Call Today216.600.0114
Spangenberg Shibley & Liber, LLC | May 3, 2014

MRI Contrast Agents Linked to Skin Disorder

Categories: News
The FDA has recently updated an earlier Public Health Advisory concerning Gadolinium-based MRI Contrast Agents which are drugs injected into patients in Magnetic Resonance Imaging (MRI) and Magnetic Resonance Angiography (MRA) procedures.